上岸了,但200亿拿什么实现?信达生物请回答

健识局
28 Mar

3月27日,创新药板块难得地出现了一波全线大涨。恒生创新药指数涨超5%。迈威生物、三生制药、科伦博泰、荣昌生物等均收获10%上下的涨幅。这股涨势甚至延续到了3月28日。信达生物无疑是其中表现最突出的,连续两天累计上涨近20%,股价创下今年新高。信达生物3月27日发布2024年财报显示,去年信达生物实现营业收入94.22亿元,同比增加51.8%;按国际财务报告准则计算,亏损大幅缩减90.8%,收缩至...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10